Viela Bio

Viela Bio: UPLINZA® (inebilizumab, anti-CD19 mAb) on the market for the treatment of neuromyelitis optica spectrum disorder (NMOSD). Additional trials with inebilizumab ongoing, including Ph 3 trials in myasthenia gravis and IgG4-related disease. VIB7734, anti-ILT7 mAb, Ph 2 trial to initiate in 1H21. Ph 2 trials ongoing for VIB4920 (Anti-CD40L-Tn3 Fusion Protein) in Sjogren's Syndrome and kidney transplant rejection.
Based in...
US - South Atlantic
Clinical Stage
Marketed, Phase III, Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Dermatology
Public, USA
Market Cap
1B +
One MedImmune Way
Fifth Floor, Suite Area Two
Gaithersburg, MD 20878
United States

Company Participants at Solebury Trout Virtual Management Access Event - 1x1 conference calls

  • Zhengbin Yao, PhD, CEO

Top 10 Holders of Viela Bio, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 15.35 7,820,950 272.72 13F 9/30/20
Temasek Holdings Pte Ltd. 7.99 4,070,330 141.93 13F 9/30/20
Hillhouse Capital Advisors Ltd. (Cayman Islands) 4.86 2,477,631 86.39 13F 9/30/20
The Vanguard Group, Inc. 4.09 2,086,087 72.74 Funds 12/31/20
Vanguard Group, Inc. (Subfiler) 3.79 1,932,093 67.37 13F 9/30/20
HBM Partners AG (Investment Management) 3.19 1,750,000 61.02 Stakes 4/15/20
Cormorant Asset Management LP 3.11 1,585,000 55.27 13F 9/30/20
State Street Corp. 2.31 1,178,422 41.09 13F 9/30/20
JPMorgan Investment Management, Inc. 1.90 966,802 33.71 13F 9/30/20
Viking Global Investors LP 1.65 843,000 29.40 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.